103 related articles for article (PubMed ID: 7704495)
1. A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group.
Furuse K; Kubota K; Kawahara M; Ogawara M; Kinuwaki E; Motomiya M; Nishiwaki Y; Niitani H; Sakuma A
Lung Cancer; 1994 Dec; 11(5-6):385-91. PubMed ID: 7704495
[TBL] [Abstract][Full Text] [Related]
2. Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.
Vokes EE; Rosenberg RK; Jahanzeb M; Craig JB; Gralla RJ; Belani CP; Jones SE; Bigley JW; Hohneker JA
J Clin Oncol; 1995 Mar; 13(3):637-44. PubMed ID: 7533824
[TBL] [Abstract][Full Text] [Related]
3. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
Le Chevalier T; Brisgand D; Douillard JY; Pujol JL; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S
J Clin Oncol; 1994 Feb; 12(2):360-7. PubMed ID: 8113844
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of Navelbine (vinorelbine) in the treatment of non-small-cell lung cancer.
Depierre A; Lemarie E; Dabouis G; Garnier G; Jacoulet P; Dalphin JC
Am J Clin Oncol; 1991 Apr; 14(2):115-9. PubMed ID: 1851385
[TBL] [Abstract][Full Text] [Related]
5. Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial.
Depierre A; Chastang C; Quoix E; Lebeau B; Blanchon F; Paillot N; Lemarie E; Milleron B; Moro D; Clavier J
Ann Oncol; 1994 Jan; 5(1):37-42. PubMed ID: 8172790
[TBL] [Abstract][Full Text] [Related]
6. Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.
Khuri FR; Rigas JR; Figlin RA; Gralla RJ; Shin DM; Munden R; Fox N; Huyghe MR; Kean Y; Reich SD; Hong WK
J Clin Oncol; 2001 May; 19(10):2626-37. PubMed ID: 11352954
[TBL] [Abstract][Full Text] [Related]
7. A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non--small-cell lung cancer.
Perng RP; Shih JF; Chen YM; Delgado FM; Tsai CM; Chou KC; Liu JM; Chern MS; Whang-Peng J
Am J Clin Oncol; 2000 Feb; 23(1):60-4. PubMed ID: 10683080
[TBL] [Abstract][Full Text] [Related]
8. Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study.
Gridelli C; Perrone F; Gallo C; De Marinis F; Ianniello G; Cigolari S; Cariello S; Di Costanzo F; D'Aprile M; Rossi A; Migliorino R; Bartolucci R; Bianco AR; Pergola M; Monfardini S
Eur J Cancer; 1997 Mar; 33(3):392-7. PubMed ID: 9155522
[TBL] [Abstract][Full Text] [Related]
9. Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small-cell lung cancer (NSCLC). The Japan Vinorelbine Lung Cancer Cooperative Study Group.
Furuse K; Fukuoka M; Kuba M; Yamori S; Nakai Y; Negoro S; Katagami N; Takada Y; Kinuwaki E; Kawahara M; Kubota K; Sakuma A; Niitani H
Ann Oncol; 1996 Oct; 7(8):815-20. PubMed ID: 8922195
[TBL] [Abstract][Full Text] [Related]
10. Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor.
Crawford J; O'Rourke MA
Semin Oncol; 1994 Oct; 21(5 Suppl 10):73-8. PubMed ID: 7526467
[TBL] [Abstract][Full Text] [Related]
11. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
[TBL] [Abstract][Full Text] [Related]
12. Phase I/II trial of paclitaxel and vinorelbine in advanced non-small cell lung cancer.
Grunberg SM; Dugan MC; Greenblatt MS; Ospina DJ; Valentine JW
Cancer Invest; 2005; 23(5):392-8. PubMed ID: 16193638
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of vinorelbine, mitomycin C and cisplatin chemotherapy for advanced non-small cell lung cancer.
Kwon MR; Jeong TY; Yuh YJ; Kim SR
Korean J Intern Med; 2002 Dec; 17(4):240-4. PubMed ID: 12647638
[TBL] [Abstract][Full Text] [Related]
14. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
15. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
[TBL] [Abstract][Full Text] [Related]
16. Phase II study with vinorelbine and cisplatin in advanced non-small cell lung cancer after failure of previous chemotherapy.
Chen YM; Lee CS; Lin WC; Tsai CM; Perng RP
J Chin Med Assoc; 2003 Apr; 66(4):241-6. PubMed ID: 12854877
[TBL] [Abstract][Full Text] [Related]
17. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.
Goa KL; Faulds D
Drugs Aging; 1994 Sep; 5(3):200-34. PubMed ID: 7803948
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of alternating doses of vinorelbine in combination with cisplatin for non-small cell lung cancer (NSCLC): a disappointing experience.
Westeel V; Jacoulet P; Breton JL; Garnier G; Mercier M; Depierre A
Lung Cancer; 1996 Dec; 16(1):61-73. PubMed ID: 9017585
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
Lena MD; Ramlau R; Hansen O; Lorusso V; Wagner L; Barni S; Cristovao MM; Huber R; Alberola V; Mitrovic M; Colin C; Gasmi J
Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer.
Crawford J; O'Rourke M; Schiller JH; Spiridonidis CH; Yanovich S; Ozer H; Langleben A; Hutchins L; Koletsky A; Clamon G; Burman S; White R; Hohneker J
J Clin Oncol; 1996 Oct; 14(10):2774-84. PubMed ID: 8874339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]